Log in to save to my catalogue

Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a

Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_446963852

Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a

About this item

Full title

Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a

Author / Creator

Publisher

New York: Business Wire

Journal title

Business Wire, 1998, p.1

Language

English

Publication information

Publisher

New York: Business Wire

More information

Scope and Contents

Contents

(BUSINESS WIRE)--March 20, 1997--Oscar Gruss & Son Incorporated, has initiated coverage of Cypress Bioscience, Inc., San Diego, CA, with a Speculative BUY recommendation. (NASDAQ: CYPB). Cypress Bioscience, Inc., researches, develops, manufactures, and markets medical devices and therapeutics for immune diseases and is developing a novel platelet s...

Alternative Titles

Full title

Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_446963852

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_446963852

How to access this item